Advancement in biomarker based effective diagnosis of neonatal sepsis

References

• Molloy EJ, Wynn JL, Bliss J, et al. Neonatal sepsis: need for consensus definition, collaboration and core outcomes. Pediatr Res. 2020;88(1):2–4.
   PubMed Web of Science ®Google Scholar
• Jyoti A, Kumar S, Srivastava VK, et al. Neonatal sepsis at point of care. Clin Chim Acta. 2021;521:45–58.
   PubMed Web of Science ®Google Scholar
• Ko MH-J, Chang H-Y, Li S-T, et al. An 18-year retrospective study on the epidemiology of early-onset neonatal sepsis-emergence of uncommon pathogens. Pediatr Neonatol. 2021;62(5):491–498.
   PubMed Web of Science ®Google Scholar
• Glaser MA, Hughes LM, Jnah A, et al. Neonatal sepsis: a review of pathophysiology and current management strategies. Adv Neonatal Care. 2021;21(1):49–60.
   PubMed Web of Science ®Google Scholar
• Qazi SA, Stoll BJ. Neonatal sepsis: a major global public health challenge. Pediatr Infect Dis J. 2009;28(1 Suppl):S1–S2.
   PubMed Web of Science ®Google Scholar
• Karabulut B, Arcagok BC. New diagnostic possibilities for early onset neonatal sepsis: red cell distribution width to platelet ratio. Fetal Pediatr Pathol. 2020;39(4):297–306.
   PubMed Web of Science ®Google Scholar
• Satar M, Arısoy AE, Çelik İH. Turkish neonatal society guideline on neonatal infections-diagnosis and treatment. Turk Pediatri Ars. 2018;53(Suppl 1):S88–S100.
   PubMedGoogle Scholar
• Shah BA, Padbury JF. Neonatal sepsis: an old problem with new insights. Virulence. 2014;5(1):170–178.
   PubMed Web of Science ®Google Scholar
• Procianoy RS, Silveira RC. The challenges of neonatal sepsis management. J Pediatr (Rio J). 2020;96 Suppl 1(Suppl 1):80–86.
   PubMedGoogle Scholar
• Wynn JL. Defining neonatal sepsis. Curr Opin Pediatr. 2016;28(2):135–140.
   PubMed Web of Science ®Google Scholar
• Bethou A, Bhat BV. Neonatal sepsis—newer insights. Indian J Pediatr. 2022;89(3):267–273.
   PubMed Web of Science ®Google Scholar
• Raimondi F, Ferrara T, Maffucci R, et al. Neonatal sepsis: a difficult diagnostic challenge. Clin Biochem. 2011;44(7):463–464.
   PubMed Web of Science ®Google Scholar
• Kurul Ş, Simons SH, Ramakers CR, et al. Association of inflammatory biomarkers with subsequent clinical course in suspected late onset sepsis in preterm neonates. Crit Care. 2021;25(1):1–10.
   PubMed Web of Science ®Google Scholar
• Martínez-Sagasti F, Velasco-López E, Domingo-Marín S, et al. Usefulness of biomarkers on infection management: with or without them? Rev Esp Quimioter. 2018;31 Suppl 1(Suppl 1):43–46.
   PubMedGoogle Scholar
• Trivedi R, Amer A, Patel R, et al. Comparison of a rapid Semi-Quantitative latex agglutination slide method against quantitative particle enhanced turbidimetric immunoassay for measurement of C-ReactiveProtein. Int J Med Biomed Sci. 2019;3(5):190–195.
   Google Scholar
• Ebenebe CU, Hesse F, Blohm ME, et al. Diagnostic accuracy of interleukin-6 for early-onset sepsis in preterm neonates. J Matern-Fetal Neonatal Med. 2021;34(2):253–258.
   PubMed Web of Science ®Google Scholar
• Verma MS, Tsaloglou M-N, Sisley T, et al. Sliding-strip microfluidic device enables ELISA on paper. Biosens Bioelectron. 2018;99:77–84.
   PubMed Web of Science ®Google Scholar
• Oeser C, Pond M, Butcher P, et al. PCR for the detection of pathogens in neonatal early onset sepsis. PLoS One. 2020;15(1):e0226817.
   PubMed Web of Science ®Google Scholar
• Yoon J, Cho H-Y, Shin M, et al. Flexible electrochemical biosensors for healthcare monitoring. J Mater Chem B. 2020;8(33):7303–7318.
   PubMed Web of Science ®Google Scholar
• Kaya HO, Cetin AE, Azimzadeh M, et al. Pathogen detection with electrochemical biosensors: advantages, challenges and future perspectives. J Electroanal Chem (Lausanne). 2021;882:114989.
   PubMed Web of Science ®Google Scholar
• Huang X, Xu D, Chen J, et al. Smartphone-based analytical biosensors. Analyst. 2018;143(22):5339–5351.
   PubMed Web of Science ®Google Scholar
• Sun AC, Hall DA. Point‐of‐care smartphone‐based electrochemical biosensing. Electroanalysis. 2019;31(1):2–16.
   Web of Science ®Google Scholar
• La M. Electrochemical, electrochemiluminescent and photoelectrochemical immunosensors for procalcitonin detection: a review. Int J Electrochem Sci. 2020;15(7):6436–6447.
   Web of Science ®Google Scholar
• Tsounidi D, Petrou PS, Raptis I. Current progress on biosensors and point-of-Care devices for sepsis diagnosis. IEEE Sens J. 2021;21(11):12840–12855.
   Web of Science ®Google Scholar
• Murković I, Steinberg MD, Murković B. Sensors in neonatal monitoring: current practice and future trends. THC. 2003;11(6):399–412.
   Google Scholar
• Iroh Tam P-Y, Bendel CM. Diagnostics for neonatal sepsis: current approaches and future directions. Pediatr Res. 2017;82(4):574–583.
   PubMed Web of Science ®Google Scholar
• Hedegaard SS, Wisborg K, Hvas A-M. Diagnostic utility of biomarkers for neonatal sepsis–a systematic review. Infect Dis (Lond). 2015;47(3):117–124.
   PubMed Web of Science ®Google Scholar
• Balayan S, Chauhan N, Chandra R, et al. Recent advances in developing biosensing based platforms for neonatal sepsis. Biosens Bioelectron. 2020;169:112552.
   PubMed Web of Science ®Google Scholar
• Yochpaz S, Friedman N, Zirkin S, et al. C-reactive protein in early-onset neonatal sepsis–a cutoff point for CRP value as a predictor of early-onset neonatal sepsis in term and late preterm infants early after birth? J Maternal-Fetal Neonatal Med. 2022;35(23):4552–4557.
   PubMed Web of Science ®Google Scholar
• Park IH, Lee SH, Yu ST, et al. Serum procalcitonin as a diagnostic marker of neonatal sepsis. Korean J Pediatr. 2014;57(10):451–456.
   PubMedGoogle Scholar
• Boseila S, Seoud I, Samy G, et al. Serum neopterin level in early onset neonatal sepsis. J Am Sci. 2011;7(7):343–352.
   Google Scholar
• El-Masry HM, Hassan A-EA, Amin HH, et al. Evaluation of serum presepsin concentrations as a biomarker of sepsis in high-risk neonates. Al-Azhar Assiut Med J. 2021;19(1):160.
   Google Scholar
• Ganesan P, Shanmugam P, Sattar SBA, et al. Evaluation of IL-6, CRP and hs-CRP as early markers of neonatal sepsis. J Clin Diagn Res. 2016;10(5):DC13–DC17.
   PubMed Web of Science ®Google Scholar
• Bharti AK, Verma MK, Gupta A, et al. Role of procalcitonin in diagnosis of neonatal sepsis and procalcitonin guided duration of antibiotic therapy. 2020.
   Google Scholar
• Ahmed AM, Mohammed AT, Bastawy S, et al. Serum biomarkers for the early detection of the early-onset neonatal sepsis: a single-center prospective study. Adv Neonatal Care. 2019;19(5):E26–E32.
   PubMed Web of Science ®Google Scholar
• Edmond K, Zaidi A. New approaches to preventing, diagnosing, and treating neonatal sepsis. PLoS Med. 2010;7(3):e1000213.
   PubMed Web of Science ®Google Scholar
• Zea-Vera A, Ochoa TJ. Challenges in the diagnosis and management of neonatal sepsis. J Trop Pediatr. 2015;61(1):1–13.
   PubMed Web of Science ®Google Scholar
• Rajeev D, Honnumurthy J, Avinash S. Predictability of biomarkers in diagnosis of neonatal sepsis: a cross sectional study. Int J Contemp Pediatr. 2016;3(2):485.
   Google Scholar
• Tejaswi Nandan D, Vijay M. Assessment of the expenses and benefits of procalcitonin testing in the diagnosis of early onset neonatal sepsis. Eur J Mol Clin Med. 2021;7(9):2798–2805.
   Google Scholar
• Cetinkaya M, Özkan H, Köksal N, et al. Comparison of serum amyloid a concentrations with those of C-reactive protein and procalcitonin in diagnosis and follow-up of neonatal sepsis in premature infants. J Perinatol. 2009;29(3):225–231.
   PubMed Web of Science ®Google Scholar
• Al-Azaowi OA, El-Kaream A, Samir A, et al. Procalcitonin as a diagnostic marker for neonatal sepsis. J Biosci Appl Res. 2018;4(4):432–443.
   Google Scholar
• Aloisio E, Dolci A, Panteghini M. Procalcitonin: between evidence and critical issues. Clin Chim Acta. 2019;496:7–12.
   PubMed Web of Science ®Google Scholar
• Abd Elkhalek HM, Abed N, Abdel Haie O, et al. Role of serum amyloid a protein in the early detection of late onset sepsis in neonate. Benha Med J. 2020;0(0):0–0.
   Google Scholar
• Wu F, Hou X, Sun R, et al. The predictive value of joint detection of serum amyloid protein A, PCT, and Hs-CRP in the diagnosis and efficacy of neonatal septicemia. Eur Rev Med Pharmacol Sci. 2019;23(13):5904–5911.
   PubMed Web of Science ®Google Scholar
• Dessì A, Pravettoni C, Ottonello G, et al. Neonatal sepsis. J Pediatr Neonatal Individual Med (JPNIM). 2014;3(2):e030273–e.
   Google Scholar
• Leante-Castellanos JL, de Guadiana-Romualdo LG, Fuentes-Gutiérrez C, et al. The value of lipopolysaccharide binding protein for diagnosis of late-onset neonatal sepsis in very low birth weight infants. J Perinat Med. 2015;43(2):253–257.
   PubMed Web of Science ®Google Scholar
• Pavcnik-Arnol M, Hojker S, Derganc M. Lipopolysaccharide-binding protein in critically ill neonates and children with suspected infection: comparison with procalcitonin, interleukin-6, and C-reactive protein. Intensive Care Med. 2004;30(7):1454–1460.
   PubMed Web of Science ®Google Scholar
• Groselj-Grenc M, Ihan A, Pavcnik-Arnol M, et al. Neutrophil and monocyte CD64 indexes, lipopolysaccharide-binding protein, procalcitonin and C-reactive protein in sepsis of critically ill neonates and children. Intensive Care Med. 2009;35(11):1950–1958.
   PubMed Web of Science ®Google Scholar
• Sharma A, Thakur A, Bhardwaj C, et al. Potential biomarkers for diagnosing neonatal sepsis. Curr Med Res Pract. 2020;10(1):12–17.
   Google Scholar
• Bhowmik A, Samanta M, Hazra A, et al. Study to evaluate the role of TNFa, IL1ß, IL6 in diagnosis and severity assessment of neonatal sepsis among term, appropriate for gestational age newborns. Perinatal J. 2021;29(3):179–185.
   Google Scholar
• Prashant A, Vishwanath P, Kulkarni P, et al. Comparative assessment of cytokines and other inflammatory markers for the early diagnosis of neonatal sepsis–a case control study. PLoS One. 2013;8(7):e68426.
   PubMed Web of Science ®Google Scholar
• Boskabadi H, Zakerihamidi M. Evaluate the diagnosis of neonatal sepsis by measuring interleukins: a systematic review. Pediatr Neonatol. 2018;59(4):329–338.
   PubMed Web of Science ®Google Scholar
• Mussap M, Noto A, Cibecchini F, et al. Emerging biomarkers in neonatal sepsis. Drugs Fut. 2012;37(5):353.
   Web of Science ®Google Scholar
• Kocabaş E, Sarikçioğlu A, Aksaray N, et al. Role of procalcitonin, C-reactive protein, interleukin-6, interleukin-8 and tumor necrosis factor-alpha in the diagnosis of neonatal sepsis. Turk J Pediatr. 2007;49(1):7–20.
   PubMed Web of Science ®Google Scholar
• Gilfillan M, Bhandari V. Neonatal sepsis biomarkers: where are we now. RRN. 2019;ume 9:9–20.
   Google Scholar
• Mally P, Xu J, Hendricks-Munoz KD. Biomarkers for neonatal sepsis: recent developments. Res Rep Neonatol. 2014;4:157–168.
   Google Scholar
• El-Madbouly AA, El Sehemawy AA, Eldesoky NA, et al. Utility of presepsin, soluble triggering receptor expressed on myeloid cells-1, and neutrophil CD64 for early detection of neonatal sepsis. Infect Drug Resist. 2019;12:311–319.
   PubMed Web of Science ®Google Scholar
• Wang K, Bhandari V, Chepustanova S, et al. Which biomarkers reveal neonatal sepsis? PLoS One. 2013;8(12):e82700.
   PubMed Web of Science ®Google Scholar
• Fouad NA, Fouad MA, Assar EH, et al. Combination of procalcitonin, CRP and CD11b biomarkers in early detection of neonatal sepsis. Egypt J Immunol. 2020;27(1):77–86.
   PubMedGoogle Scholar
• Hashem HE, Ibrahim ZH, Ahmed WO. Diagnostic, prognostic, predictive, and monitoring role of neutrophil CD11b and monocyte CD14 in neonatal sepsis. Dis Markers. 2021;2021:4537760–4537712.
   PubMedGoogle Scholar
• Delanghe JR, Speeckaert MM. Translational research and biomarkers in neonatal sepsis. Clin Chim Acta. 2015;451(Pt A):46–64.
   PubMedGoogle Scholar
• Awad H-M, Hawary M-A, Kholef EFM, et al. Serum neopterin level in early onset neonatal sepsis. Egypt J Hosp Med. 2020;81(1):1193–1203.
   Google Scholar
• Singh Laishram R, Khuraijam D. R. Hematological and biological markers of neonatal sepsis. Iran J Pathol. 2013;8(3):137–146.
   Google Scholar
• Hincu M-A, Zonda G-I, Stanciu GD, et al. Relevance of biomarkers currently in use or research for practical diagnosis approach of neonatal early-onset sepsis. Children. 2020;7(12):309.
   PubMedGoogle Scholar
• Kumar N, Dayal R, Singh P, et al. A comparative evaluation of presepsin with procalcitonin and CRP in diagnosing neonatal sepsis. Indian J Pediatr. 2019;86(2):177–179.
   PubMed Web of Science ®Google Scholar
• Rowisha MA, Ibrahim AM, Saad MA. Presepsin as an early diagnostic marker of neonatal sepsis in preterm neonate.
   Google Scholar
• Poggi C, Bianconi T, Gozzini E, et al. Presepsin for the detection of late-onset sepsis in preterm newborns. Pediatrics. 2015;135(1):68–75.
   PubMed Web of Science ®Google Scholar
• Montaldo P, Rosso R, Santantonio A, et al. Presepsin for the detection of early-onset sepsis in preterm newborns. Pediatr Res. 2017;81(2):329–334.
   PubMed Web of Science ®Google Scholar
• Rao L, Song Z, Yu X, et al. Progranulin as a novel biomarker in diagnosis of early-onset neonatal sepsis. Cytokine. 2020;128:155000.
   PubMed Web of Science ®Google Scholar
• Yang K-D, He Y, Xiao S, et al. Identification of progranulin as a novel diagnostic biomarker for early-onset sepsis in neonates. Eur J Clin Microbiol Infect Dis. 2020;39(12):2405–2414.
   PubMed Web of Science ®Google Scholar
• Cantey JB, Bultmann CR. C-reactive protein testing in late-onset neonatal sepsis: hazardous waste. JAMA Pediatr. 2020;174(3):235–236.
   PubMed Web of Science ®Google Scholar
• Avan A, Tavakoly Sany SB, Ghayour‐Mobarhan M, et al. Serum C‐reactive protein in the prediction of cardiovascular diseases: overview of the latest clinical studies and public health practice. J Cell Physiol. 2018;233(11):8508–8525.
   PubMed Web of Science ®Google Scholar
• Totan M, Antonescu E, Catana MG, et al. C-reactive protein-A predictable biomarker in ischemic stroke. Rev Chim. 2019;70(6):2290–2293.
   Web of Science ®Google Scholar
• Vuong NL, Le Duyen HT, Lam PK, et al. C-reactive protein as a potential biomarker for disease progression in dengue: a multi-country observational study. BMC Med. 2020;18(1):35.
   PubMed Web of Science ®Google Scholar
• Karaboğa MNS, Sezgintürk MK. A novel silanization agent based single used biosensing system: detection of C-reactive protein as a potential alzheimer’s disease blood biomarker. J Pharm Biomed Anal. 2018;154:227–235.
   PubMed Web of Science ®Google Scholar
• Shrotriya S, Walsh D, Nowacki AS, et al. Serum C-reactive protein is an important and powerful prognostic biomarker in most adult solid tumors. PLoS One. 2018;13(8):e0202555.
   PubMed Web of Science ®Google Scholar
• Tan C, Huang Y, Shi F, et al. C‐reactive protein correlates with computed tomographic findings and predicts severe COVID‐19 early. J Med Virol. 2020;92(7):856–862.
   PubMed Web of Science ®Google Scholar
• Sharifpour M, Rangaraju S, Liu M, et al. C-Reactive protein as a prognostic indicator in hospitalized patients with COVID-19. PLoS One. 2020;15(11):e0242400.
   PubMed Web of Science ®Google Scholar
• Wang L. C-reactive protein levels in the early stage of COVID-19. Med Mal Infect. 2020;50(4):332–334.
   PubMed Web of Science ®Google Scholar
• Sahu BR, Kampa RK, Padhi A, et al. C-reactive protein: a promising biomarker for poor prognosis in COVID-19 infection. Clin Chim Acta. 2020;509:91–94.
   PubMed Web of Science ®Google Scholar
• Eschborn S, Weitkamp J-H. Procalcitonin versus C-reactive protein: review of kinetics and performance for diagnosis of neonatal sepsis. J Perinatol. 2019;39(7):893–903.
   PubMed Web of Science ®Google Scholar
• Tessema B, Lippmann N, Willenberg A, et al. The diagnostic performance of interleukin-6 and C-reactive protein for early identification of neonatal sepsis. Diagnostics. 2020;10(11):978.
   Web of Science ®Google Scholar
• Song Y, Chen Y, Dong X, et al. Diagnostic value of neutrophil CD64 combined with CRP for neonatal sepsis: a meta-analysis. Am J Emerg Med. 2019;37(8):1571–1576.
   PubMed Web of Science ®Google Scholar
• Edgar JDM, Gabriel V, Gallimore JR, et al. A prospective study of the sensitivity, specificity and diagnostic performance of soluble intercellular adhesion molecule 1, highly sensitive C-reactive protein, soluble E-selectin and serum amyloid a in the diagnosis of neonatal infection. BMC Pediatr. 2010;10(1):22.
   PubMedGoogle Scholar
• Lam HS, Ng PC. Biochemical markers of neonatal sepsis. Pathology. 2008;40(2):141–148.
   PubMed Web of Science ®Google Scholar
• Datla S, Kitchanan S, Sethuraman G. Diagnostic reliability of salivary C-reactive protein as an alternative noninvasive biomarker of neonatal sepsis. Indian Pediatr. 2021;58(8):745–748.
   PubMed Web of Science ®Google Scholar
• Barekatain B, HasanGhalyaei N, Mohammadizadeh M, et al. Investigation of salivary C-reactive protein and interleukin-18 for the diagnosis of neonatal sepsis. J Res Med Sci. 2021;26(1):131.
   PubMed Web of Science ®Google Scholar
• Tanak AS, Jagannath B, Tamrakar Y, et al. Non-faradaic electrochemical impedimetric profiling of procalcitonin and C-reactive protein as a dual marker biosensor for early sepsis detection. Anal Chim Acta X. 2019;3:100029.
   PubMedGoogle Scholar
• Liu C, Fang C, Xie L. Diagnostic utility of procalcitonin as a biomarker for late-onset neonatal sepsis. Transl Pediatr. 2020;9(3):237–242.
   PubMed Web of Science ®Google Scholar
• Mithal LB, Palac HL, Yogev R, et al. Cord blood acute phase reactants predict early onset neonatal sepsis in preterm infants. PLoS One. 2017;12(1):e0168677.
   PubMed Web of Science ®Google Scholar
• Zhang J, Oueslati R, Cheng C, et al. Rapid, highly sensitive detection of gram-negative bacteria with lipopolysaccharide based disposable aptasensor. Biosens Bioelectron. 2018;112:48–53.
   PubMed Web of Science ®Google Scholar
• Wu Z, Zhang Z, Lei Z, et al. CD14: biology and role in the pathogenesis of disease. Cytokine Growth Factor Rev. 2019;48:24–31.
   PubMed Web of Science ®Google Scholar
• Ye Q, Du L-Z, Shao W-X, et al. Utility of cytokines to predict neonatal sepsis. Pediatr Res. 2017;81(4):616–621.
   PubMed Web of Science ®Google Scholar
• Leal YA, Álvarez-Nemegyei J, Lavadores-May AI, et al. Cytokine profile as diagnostic and prognostic factor in neonatal sepsis. J Matern-Fetal Neonatal Med. 2019;32(17):2830–2836.
   PubMed Web of Science ®Google Scholar
• Celik İH, Demirel FG, Uras N, et al. What are the cut‐off levels for IL‐6 and CRP in neonatal sepsis? J Clin Lab Anal. 2010;24(6):407–412.
   PubMed Web of Science ®Google Scholar
• Camacho-Gonzalez A, Spearman PW, Stoll BJ. Neonatal infectious diseases: evaluation of neonatal sepsis. Pediatr Clin. 2013;60(2):367–389.
   PubMed Web of Science ®Google Scholar
• Deleon C, Shattuck K, Jain SK. Biomarkers of neonatal sepsis. NeoReviews. 2015;16(5):e297–e308.
   Google Scholar
• Zhou M, Cheng S, Yu J, et al. Interleukin-8 for diagnosis of neonatal sepsis: a meta-analysis. PLoS One. 2015;10(5):e0127170.
   PubMed Web of Science ®Google Scholar
• Ucar B, Yildiz B, Aksit MA, et al. Serum amyloid A, procalcitonin, tumor necrosis factor-, and interleukin-1 levels in neonatal Late-Onset sepsis. Mediators Inflamm. 2008;2008:737141–737147.
   PubMed Web of Science ®Google Scholar
• Lv B, Huang J, Yuan H, et al. Tumor necrosis factor-α as a diagnostic marker for neonatal sepsis: a meta-analysis. Sci World J. 2014;2014:1–14.
   Google Scholar
• Fattah M, Al Fadhil AO, Asaif S, et al. Utility of cytokine, adhesion molecule and acute phase proteins in early diagnosis of neonatal sepsis. J Nat Sci Biol Med. 2017;8(1):32–39.
   PubMedGoogle Scholar
• Arunachalam AR, Pammi M. Biomarkers in early-onset neonatal sepsis: an update. Ann Clin Med Microbio. 2015;1(2):1007.
   Google Scholar
• El Shimi MS, Abou Shady NM, Hamed GM, et al. Significance of neutrophilic CD64 as an early marker for detection of neonatal sepsis and prediction of disease outcome. J Maternal-Fetal Neonatal Med. 2017;30(14):1709–1714.
   PubMed Web of Science ®Google Scholar
• Abd Elkareem RM, Ahmed HM, Meabed MH, et al. Diagnostic value of CD64 in early detection of neonatal sepsis. Comp Clin Pathol. 2020;29(3):639–643.
   Google Scholar
• ELMeneza S, Mohamed W, Elbagoury I, et al. Role of neutrophil CD11b expression in diagnosis of earlyonset neonatal sepsis in full-term infant. Clin Exp Pediatr. 2021;64(1):44–45.
   PubMedGoogle Scholar
• Qiu X, Li J, Yang X, et al. Is neutrophil CD11b a special marker for the early diagnosis of sepsis in neonates? A systematic review and meta-analysis. BMJ Open. 2019;9(4):e025222.
   PubMed Web of Science ®Google Scholar
• Heo JS. Neutrophil CD11b as a promising marker for early detection of neonatal sepsis. Clin Exp Pediatr. 2021;64(1):28–30.
   PubMedGoogle Scholar
• Saeed OG, Zamzam SM, Elnga AMA, et al. Sepsis markers at PICU and the utility of serum neopterin. Eur J Mol Clin Med. 2021;8(3):3813–3823.
   Google Scholar
• Centi S, Tombelli S, Puntoni M, et al. Detection of biomarkers for inflammatory diseases by an electrochemical immunoassay: the case of neopterin. Talanta. 2015;134:48–53.
   PubMed Web of Science ®Google Scholar
• Selvolini G, Marrazza G. MIP-based sensors: promising new tools for cancer biomarker determination. Sensors. 2017;17(4):718.
   PubMed Web of Science ®Google Scholar
• Kojic D, Siegler BH, Uhle F, et al. Are there new approaches for diagnosis, therapy guidance and outcome prediction of sepsis? World J Exp Med. 2015;5(2):50–63.
   PubMedGoogle Scholar
• Zou Q, Wen W, Zhang X. Presepsin as a novel sepsis biomarker. World J Emerg Med. 2014;5(1):16–19.
   PubMedGoogle Scholar
• Parri N, Trippella G, Lisi C, et al. Accuracy of presepsin in neonatal sepsis: systematic review and meta-analysis. Expert Rev Anti Infect Ther. 2019;17(4):223–232.
   PubMed Web of Science ®Google Scholar
• Huang M, Cai S, Su J. The pathogenesis of sepsis and potential therapeutic targets. Int J Mol Sci. 2019;20(21):5376.
   PubMed Web of Science ®Google Scholar
• Mahmoud Zayed K, Abd ELmoez Ali Saad A, Mohamed Amin W, et al. Diagnostic value of presepsin in detection of early-onset neonatal sepsis. Al-Azhar J Pediatr. 2020;23(2):825–851.
   Google Scholar
• Memar MY, Baghi HB. Presepsin: a promising biomarker for the detection of bacterial infections. Biomed Pharmacother. 2019;111:649–656.
   PubMed Web of Science ®Google Scholar
• Sleegers K, Brouwers N, Van Broeckhoven C. Role of progranulin as a biomarker for alzheimer’s disease. Biomark Med. 2010;4(1):37–50.
   PubMed Web of Science ®Google Scholar
• Edelman MJ, Feliciano J, Yue B, et al. GP88 (progranulin): a novel tissue and circulating biomarker for non–small cell lung carcinoma. Hum Pathol. 2014;45(9):1893–1899.
   PubMed Web of Science ®Google Scholar
• Ghidoni R, Paterlini A, Benussi L. Circulating progranulin as a biomarker for neurodegenerative diseases. Am J Neurodegen Dis. 2012;1(2):180.
   PubMedGoogle Scholar
• Z Oikonomakou M, Gkentzi D, Gogos C, et al. Biomarkers in pediatric sepsis: a review of recent literature. Biomark Med. 2020;14(10):895–917.
   PubMed Web of Science ®Google Scholar
• Chauhan N, Tiwari S, Jain U. Potential biomarkers for effective screening of neonatal sepsis infections: an overview. Microb Pathog. 2017;107:234–242.
   PubMed Web of Science ®Google Scholar
• Soto S, Bosch J, Jimenez de Anta M, et al. Comparative study of virulence traits of Escherichia coli clinical isolates causing early and late neonatal sepsis. J Clin Microbiol. 2008;46(3):1123–1125.
   PubMed Web of Science ®Google Scholar
• Rajagopal L. Understanding the regulation of group B streptococcal virulence factors. 2009.
   Google Scholar
• Xie K, Kong S, Li F, et al. Bioinformatics-Based study to investigate potential differentially expressed genes and miRNAs in pediatric sepsis. Med Sci Monit. 2020;26:e923881-1.
   Web of Science ®Google Scholar
• Khaertynov KS, Boichuk S, Khaiboullina S, et al. Comparative assessment of cytokine pattern in early and late onset of neonatal sepsis. J Immunol Res. 2017;2017:8601063–8601068.
   PubMed Web of Science ®Google Scholar
• Cardoso FL, Herz J, Fernandes A, et al. Systemic inflammation in early neonatal mice induces transient and lasting neurodegenerative effects. J Neuroinflamm. 2015;12(1):82.
   PubMedGoogle Scholar
• Smith CL, Dickinson P, Forster T, et al. Identification of a human neonatal immune-metabolic network associated with bacterial infection. Nat Commun. 2014;5(1):4649.
   PubMedGoogle Scholar
• Fatmi A, Rebiahi SA, Chabni N, et al. miRNA-23b as a biomarker of culture-positive neonatal sepsis. Mol Med. 2020;26(1):1–9.
   Web of Science ®Google Scholar
• Abdelaleem OO, Mohammed SR, El Sayed HS, et al. Serum miR-34a-5p and miR-199a-3p as new biomarkers of neonatal sepsis. PLoS One. 2022;17(1):e0262339.
   PubMed Web of Science ®Google Scholar
• El-Hefnawy SM, Mostafa RG, Elfeshawy EM, et al. Biochemical and molecular study on serum miRNA-16a and miRNA-451 as neonatal sepsis biomarkers. Biochem Biophys Rep. 2021;25:100915.
   PubMedGoogle Scholar
• Huang L, Qiao L, Zhu H, et al. Genomics of neonatal sepsis: has-miR-150 targeting BCL11B functions in disease progression. Ital J Pediatr. 2018;44(1):145.
   PubMedGoogle Scholar
• Ahmad S, Ahmed MM, Hasan P, et al. Identification and validation of potential miRNAs, as biomarkers for sepsis and associated lung injury: a network-based approach. Genes (Basel). 2020;11(11):1327.
   PubMed Web of Science ®Google Scholar
• Bryan T, Luo X, Bueno PR, et al. An optimised electrochemical biosensor for the label-free detection of C-reactive protein in blood. Biosens Bioelectron. 2013;39(1):94–98.
   PubMed Web of Science ®Google Scholar
• Molinero-Fernández Á, Moreno-Guzmán M, López MÁ, et al. An array-based electrochemical magneto-immunosensor for early neonatal sepsis diagnostic: fast and accurate determination of C-reactive protein in whole blood and plasma samples. Microchem J. 2020;157:104913.
   Web of Science ®Google Scholar
• Balayan S, Chauhan N, Chandra R, et al. Electrochemical based C-Reactive protein (CRP) sensing through molecularly imprinted polymer (MIP) pore structure coupled with Bi-Metallic tuned Screen-Printed electrode. Biointerface Res Appl Chem. 2022;6:38.
   Google Scholar
• Lakshmanakumar M, Nesakumar N, Sethuraman S, et al. Fabrication of GQD-Electrodeposited Screen-Printed carbon electrodes for the detection of the CRP biomarker. ACS Omega. 2021;6(48):32528–32536.
   PubMed Web of Science ®Google Scholar
• Guillem P, Bustos R-H, Garzon V, et al. A low-cost electrochemical biosensor platform for C-reactive protein detection. Sens Bio-Sens Res. 2021;31:100402.
   Google Scholar
• Amouzadeh Tabrizi M, Acedo P. Highly sensitive RNA-Based electrochemical aptasensor for the determination of C-Reactive protein using carbon Nanofiber-Chitosan modified Screen-Printed electrode. Nanomaterials. 2022;12(3):415.
   Web of Science ®Google Scholar
• Mahyari M, Hooshmand SE, Sepahvand H, et al. Gold nanoparticles anchored onto covalent poly deep eutectic solvent functionalized graphene: an electrochemical aptasensor for the detection of C-reactive protein. Mater Chem Phys. 2021;269:124730.
   Web of Science ®Google Scholar
• Yang Z-H, Zhuo Y, Yuan R, et al. Electrochemical activity and electrocatalytic property of cobalt phthalocyanine nanoparticles-based immunosensor for sensitive detection of procalcitonin. Sens Actuators, B. 2016;227:212–219.
   Web of Science ®Google Scholar
• Molinero-Fernández Á, López MÁ, Escarpa A. An on-chip microfluidic-based electrochemical magneto-immunoassay for the determination of procalcitonin in plasma obtained from sepsis diagnosed preterm neonates. Analyst. 2020;145(14):5004–5010.
   PubMed Web of Science ®Google Scholar
• Liu J, Liu Y, Bao L, et al. Electrochemical sensitive determination of sepsis biomarker procalcitonin at graphitic carbon nitride nanosheets modified electrodes. Available at SSRN 3950172. 2021.
   Google Scholar
• Jin Y, Wu J, Hu D, et al. Development of enzyme-free immunosensor based on nanobrush and fluorescence dye for sensitive detection of procalcitonin. Dyes Pigm. 2021;193:109548.
   Web of Science ®Google Scholar
• Ding H, Yang L, Jia H, et al. Label-free electrochemical immunosensor with palladium nanoparticles functionalized MoS2/NiCo heterostructures for sensitive procalcitonin detection. Sens Actuators, B. 2020;312:127980.
   Web of Science ®Google Scholar
• Qu L, Yang L, Ren Y, et al. A signal-off electrochemical sensing platform based on Fe3S4-Pd and pineal mesoporous bioactive glass for procalcitonin detection. Sens Actuators, B. 2020;320:128324.
   Web of Science ®Google Scholar
• Balayan S, Chauhan N, Chandra R, et al. Molecular imprinting based electrochemical biosensor for identification of serum amyloid A (SAA), a neonatal sepsis biomarker. Int J Biol Macromol. 2022;195:589–597.
   PubMed Web of Science ®Google Scholar
• Xia C, Li Y, Yuan G, et al. Immunoassay for serum amyloid a using a glassy carbon electrode modified with carboxy-polypyrrole, multiwalled carbon nanotubes, ionic liquid and chitosan. Microchim Acta. 2015;182(7-8):1395–1402.
   Web of Science ®Google Scholar
• Panneer Selvam A, Prasad S. Companion and point-of-care sensor system for rapid multiplexed detection of a panel of infectious disease markers. SLAS Technol. 2017;22(3):338–347.
   PubMed Web of Science ®Google Scholar
• Russell C, Ward AC, Vezza V, et al. Development of a needle shaped microelectrode for electrochemical detection of the sepsis biomarker interleukin-6 (IL-6) in real time. Biosens Bioelectron. 2019;126:806–814.
   PubMed Web of Science ®Google Scholar
• Tanak AS, Muthukumar S, Krishnan S, et al. Multiplexed cytokine detection using electrochemical point-of-care sensing device towards rapid sepsis endotyping. Biosens Bioelectron. 2021;171:112726.
   PubMed Web of Science ®Google Scholar
• Kamakoti V, Kinnamon D, Choi KH, et al. Fully electronic urine dipstick probe for combinatorial detection of inflammatory biomarkers. Future Sci OA. 2018;4(5):FSO301.
   PubMed Web of Science ®Google Scholar
• Tang P, Zhang H, Huo J, et al. An electrochemical sensor based on iron (II, III)@ graphene oxide@ molecularly imprinted polymer nanoparticles for interleukin-8 detection in saliva. Anal Methods. 2015;7(18):7784–7791.
   Web of Science ®Google Scholar
• Li L, Li M, Wang W, et al. High sensitivity determination of TNF-α for early diagnosis of neonatal infections with a novel and reusable electrochemical sensor. Sensors. 2017;17(5):992.
   PubMed Web of Science ®Google Scholar
• Sharma PS, Wojnarowicz A, Sosnowska M, et al. Potentiometric chemosensor for neopterin, a cancer biomarker, using an electrochemically synthesized molecularly imprinted polymer as the recognition unit. Biosens Bioelectron. 2016;77:565–572.
   PubMed Web of Science ®Google Scholar
• Huang C-Y, Hsieh C-H, Chen Y-L, et al. Portable potentiostatic sensor integrated with neopterin-imprinted poly (ethylene-co-vinyl alcohol)-based electrode. IET Nanobiotechnol. 2011;5(4):126–131.
   PubMed Web of Science ®Google Scholar
• Morad EA, Rabie RA, Almalky MA, et al. Evaluation of procalcitonin, C-reactive protein, and interleukin-6 as early markers for diagnosis of neonatal sepsis. Int J Microbiol. 2020;2020:8889086–8889089.
   PubMed Web of Science ®Google Scholar
• Anugu NR, Khan S. Comparing the diagnostic accuracy of procalcitonin and C-Reactive protein in neonatal sepsis: a systematic review. Cureus. 2021;13(11):e19485.
   PubMed Web of Science ®Google Scholar
• Kamel MM, Abd-Ullah Hf E, Sayed M, et al. Presepsin as an early predictor of neonatal sepsis. Int J Pediatr. 2021;9:13359–13369.
   Web of Science ®Google Scholar
• Bellos I, Fitrou G, Pergialiotis V, et al. The diagnostic accuracy of presepsin in neonatal sepsis: a meta-analysis. Eur J Pediatr. 2018;177(5):625–632.
   PubMed Web of Science ®Google Scholar
• Iskandar A, Arthamin MZ, Indriana K, et al. Comparison between presepsin and procalcitonin in early diagnosis of neonatal sepsis. J Maternal-Fetal Neonatal Med. 2019;32(23):3903–3908.
   PubMed Web of Science ®Google Scholar
• Li S, Renick P, Senkowsky J, et al. Diagnostics for wound infections. Adv Wound Care (New Rochelle). 2021;10(6):317–327.
   PubMed Web of Science ®Google Scholar
• Molinero-Fernández Á, Moreno-Guzmán M, López MÁ, et al. Magnetic bead-based electrochemical immunoassays on-drop and on-chip for procalcitonin determination: disposable tools for clinical sepsis diagnosis. Biosensors (Basel). 2020;10(6):66.
   PubMedGoogle Scholar